Hypovitaminosis D and Organ Damage In Patients With Arterial Hypertension: A Multicenter Double Blind Randomised Controlled Trial of Cholecalciferol Supplementation (HYPODD)

Arterial Hypertension ◽

Controlled Trial ◽

Hypovitaminosis D ◽

Organ Damage ◽

Double Blind ◽

Cholecalciferol Supplementation ◽

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(08)60919-8 ◽

2008 ◽

Vol 371 (9630) ◽

pp. 2093-2100 ◽

Cited By ~ 566

Author(s):

N Galiè ◽

LJ Rubin ◽

MM Hoeper ◽

P Jansa ◽

H Al-Hiti ◽

...

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Controlled Trial ◽

Double Blind ◽

Pulmonary Arterial ◽

A MULTICENTRE DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL TO ASSESS THE CLINICAL- AND COST-EFFECTIVENESS OF FACET-JOINT INJECTIONS IN PATIENTS WITH NON-SPECIFIC LOW BACK PAIN: A FEASIBILITY STUDY

10.26226/morressier.59ad4811d462b80290b53a8a ◽

2017 ◽

Author(s):

Ahmad Alia

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Cost Effectiveness ◽

Facet Joint ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Randomised Controlled ◽

Joint Injections

Faculty Opinions recommendation of TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058963.510919 ◽

2007 ◽

Author(s):

Pascal Derkinderen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793462652 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Faculty Opinions recommendation of Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718482844.793498728 ◽

2014 ◽

Author(s):

Carlos Seas ◽

Joel Lopez

Keyword(s):

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725669310.793559015 ◽

2019 ◽

Author(s):

Stefan De Hert

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass ◽

Coronary Artery Bypass Surgery ◽

Myocardial Injury ◽

Bypass Surgery ◽

Controlled Trial ◽

Artery Bypass ◽

Double Blind ◽

Faculty Opinions recommendation of Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725552213.793516915 ◽

2016 ◽

Author(s):

Bradley Quon

Keyword(s):

Cystic Fibrosis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Faculty Opinions recommendation of High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7746956.8077054 ◽

2011 ◽

Cited By ~ 1

Author(s):

Willem J Wiersinga ◽

Gavin Koh

Keyword(s):

Vitamin D ◽

Controlled Trial ◽

Antimicrobial Treatment ◽

High Dose ◽

Double Blind ◽

Intensive Phase ◽

Vitamin D 3 ◽

Randomised Controlled ◽

High Dose Vitamin

Faculty Opinions recommendation of Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9467957.10110055 ◽

2011 ◽

Author(s):

Diederik van de Beek ◽

Matthijs Brouwer

Keyword(s):

Adjuvant Therapy ◽

Bacterial Meningitis ◽

Controlled Trial ◽

Double Blind ◽

Hiv Seroprevalence ◽

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30532-4 ◽

2021 ◽

Author(s):

Marius M Hoeper ◽

Hikmet Al-Hiti ◽

Raymond L Benza ◽

Sung-A Chang ◽

Paul A Corris ◽

...

Keyword(s):

Pulmonary Arterial Hypertension ◽

Maintenance Therapy ◽

Arterial Hypertension ◽

Controlled Trial ◽

Open Label ◽

Phosphodiesterase 5 Inhibitors ◽

Pulmonary Arterial ◽

Randomised Controlled ◽

Phosphodiesterase 5